MAR 30, 2017 10:45 AM PDT

Newly Identified Risk Loci for Gliomas

WRITTEN BY: Xuan Pham

A new research into the causes of deadly brain cancer implicates 13 new genetic regions. This doubles the number of known genetic mutations that seem to increase the risk for glioma – one of the most common forms of brain cancer.

The study was an international collaboration with researchers from Europe, the United Kingdom, and the United States. The meta-analysis included data on nearly 12,500 patients with gliomas, and over 18,000 healthy individuals.

The large sample size allowed the researchers to more precisely identify genetic susceptibility regions with a genetic tool known as a genome-wide association study (GWAS). With this analysis, they found 5 new genetic regions that increase the risk for a deadly form of glioma known as glioblastoma multiforme (GBM). They also found 8 new regions that are associated with increased risk of non-GBM tumors – a less lethal glioma type.

The genetic regions implicated in this study are linked to cell division, cell cycle regulation, neurogenesis, and regulation of some key proteins.

"The changes in the way we think about glioma could be quite fundamental," said Richard Houston, the study’s co-senior author. "So for example, what we thought of as two related subtypes of the disease turn out to have quite different genetic causes which may require different approaches to treatment."

Of note, gliomas make up about 27 percent of all brain cancers, which result in 13,000 deaths every year. In particular, the GBM form of glioma is particularly aggressive and notorious for the dismally grim 5-year survival rate of less than 10 percent.

"It has been exciting to have been involved in such a gigantic study including cases of brain cancer from all over the world. We have uncovered a treasure trove of new information about the genetic causes of glioma brain cancers,” said Houlston. “Understanding the genetics of glioma in such detail allows us to start thinking about ways of identifying people at high inherited risk, and will open up a search for new treatments that exploit our new knowledge of the biology of the disease."

Additional sources: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 20, 2019
Immunology
NOV 20, 2019
Harnessing the Power of Natural Killer Cells to Fight Cancer
Manipulating the immune system’s population of natural killer cells could bolster therapies targeting cancer. A new study saw positive results invest...
DEC 18, 2019
Cancer
DEC 18, 2019
Looking to this tropical plant for future pancreatic cancer treatments
Pancreatic cancer is a dangerous disease for two reasons: its stealth and its resistance to many anti-cancer drugs. The American Cancer Society estimates t...
JAN 02, 2020
Genetics & Genomics
JAN 02, 2020
Mysterious Extrachromosomal DNA is Linked to Childhood Cancer
Scientists are learning more about an unusual kind of DNA that's separate from a cell's genomic DNA....
JAN 02, 2020
Cancer
JAN 02, 2020
The new "tumor-on-a-chip"
In order to mimic the microenvironment of a tumor in the human body, researchers from Kyoto University have developed a device that they are describing as ...
JAN 08, 2020
Health & Medicine
JAN 08, 2020
Major Study Does Not Find Strong Link Between Talcum Powder and Cancer
Competing opinions regarding the safety of talcum powder have developed throughout the past several decades. Talc is commonly used as baby powder and is al...
JAN 10, 2020
Cancer
JAN 10, 2020
Using cancer drugs to treat COPD
Certain cancer treatments may be used effectively to treat chronic obstructive pulmonary disease (COPD), according to new research published recently in eL...
Loading Comments...